CG Invites
We strive to be a global biopharma leader whose mission is
to develop innovative, life-changing medicine
Pipeline
Polmacoxib + Pregabalin
-
Indication
Neuropathic pain (e.g., diabetic neuropathy, fibromyalgia, postherpetic neuralgia)
-
Development stage
Phase 1 clinical study completed
-
Mechanism of action and features
- Combination of polmacoxib and pregabalin for neuropathic pain
- Anti-inflammatory and analgesic effects are expected to be consistent and strong against neuropathic pain diseases
- Polmacoxib has a long half-life that increases its persistence compared to conventional anti-inflammatory analgesics.
- Pregabalin is a neuropathic pain reliever
- Safety verification through Phase 1 clinical study for healthy individuals
Polmacoxib + Pregabalin